Have Rosacea? Treat It, Don’t Conceal It

Sponsored Post

Have Rosacea? Treat It, Don’t Conceal It

I have “bad skin days.” Almost anything can set this off. Not washing my face at night, trying a new skin care product, walking to the mailbox in a stiff wind, you get the picture. The result is redness, irritation, discomfort and pain.

I have rosacea, a chronic inflammatory skin condition that can vary quite a bit for each person, but for me the symptom I primarily experience is redness. I can conceal it with makeup, but the truth is, a thick layer of products is time consuming to apply, and only covers it up. Certain makeup and skin care products can even exacerbate your rosacea, so it’s important to be selective about what you put on your face.

While everyone’s rosacea is different, you can break up with your makeup by heading to your dermatologist to learn more about potential treatment options, like Mirvaso® (brimonidine) topical gel, 0.33%*, which is great for treating the redness of rosacea, or Soolantra® (ivermectin) Cream, 1%, a once-daily, prescription topical treatment for the inflammatory lesions (bumps and pimples) of rosacea.

If you have rosacea, or think you do, head over to the Break Up with Your Makeup page to learn more about rosacea and an array of rosacea treatments! While you’re there you can enter to win an all-expenses paid trip to the Fall 2015 New York Film Festival by sharing how you stay confident even on “tough skin days” along with a no makeup selfie.

Please Activate Javascript

Sponsored Post: This post is part of the Break Up with Your Makeup program sponsored by Galderma Laboratories, L.P. You should discuss any medications with your physician, but I do think it is a great idea to visit a dermatologist for a treatment plan that is right for you!

Important Safety Information – Mirvaso® Gel*
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha-2 adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin-burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.

*Each gram of gel contains 5mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base

Important Safety Information – Soolantra® Cream
Indication: SOOLANTRA® (ivermectin) Cream, 1%, is indicated for the treatment of inflammatory lesions of rosacea. Adverse Events: In clinical trials with SOOLANTRA® Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation. Warnings / Precautions: Not for oral, ophthalmic or intravaginal use.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit WWW.FDA.GOV/MEDWATCH or call 1-800-FDA-1088

All trademarks are the property of their respective owners.


Leave a Reply

Your email address will not be published. Required fields are marked *